Parkinson’s drug therapies in the clinical trial pipeline: 2024 update
Each year, members of the Cure Parkinson’s research team collaborate with Parkinson’s research advocates and The Michael J. Fox Foundation to present an overview on the current clinical trials landscape for Parkinson’s. The 2024 report, now published in the Journal of Parkinson’s Disease (JPD), marks...
Learn more
New clinical trials targeting the LRRK2 gene
LRRK2 is a protein that becomes hyperactive in some people with Parkinson’s, and this is believed to be involved in the progression of their Parkinson’s.
Marking World Parkinson’s Day – tell us your story
Cure Parkinson’s has always had the unwavering belief that people living with Parkinson’s are key to finding the cure – and on World Parkinson’s Day we want to hear your story
Exploring the self-image of women with Parkinson’s
There is a fundamental gap in knowledge of how Parkinson’s manifests and affects women. The Parkinson’s advocate group, PD Avengers and a collection of women living with Parkinson’s have joined Fox Insight, a surveying platform created by the Michael J Fox Foundation, to design a…
2023: research highlights for the year ahead
Cure Parkinson’s is looking forward to an eventful 12 months – here we provide a summary of what’s on the horizon.
Research Update Meeting Spring 2023 – recorded to watch again
Our popular and much-awaited research update meeting brought together two leading clinicians to report on their individual area of expertise for Parkinson’s. It’s available to watch again!